Small Molecule Drug Discovery

Status

Published

on 29 Dec 2019

Year of Creation

2019

Elsevier Inc

Registration Number

TX0008949815

on 29 Dec 2019

The U.S. Copyright record (Registration Number: TX0008949815) dated 29 Dec 2019, pertains to an electronic file (eService) titled "Small Molecule Drug Discovery" created in 2019. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.

Elsevier Inc

Application Details

Registration Number

TX0008949815

Registration Date

12/29/2019

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Book, 332 p

First Publication Nation

United States

ISBN

9780128183496

Preexisting Material

permissioned materials

Personal Authors

Andrea Trabocchi

Elena Lenci

Corporate Authors

Elsevier Inc

Notes

Rights Note: permissions@elsevier.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text

Statements

Application Title Statement: Small Molecule Drug Discovery

Author Statement: Andrea Trabocchi Domicile: Italy Citizenship: Italy Authorship: text, compilation of contributions Elena Lenci Domicile: Italy Citizenship: Italy Authorship: text, compilation of contributions

Notes

Rights Note: permissions@elsevier.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text

Statements

Application Title Statement: Small Molecule Drug Discovery

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.